MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest Issue
In the ALLEVIATE-HF clinical trial, continuous monitoring provided by Medtronic’s insertable cardiac monitor revealed a substantial burden of previously unsuspected arrhythmias in patients with both HFrEF and HFpEF—many of whom would not ordinarily qualify for an implantable cardiac device.
Rajiv Sethi, who led the Seattle Spine Score initiative to make spine surgery outcomes more consistent and effective, speaks to MedTech Strategist about his move from Virginia Mason in Seattle to UCSF. His expansive new remit includes research and implementation of value-based care initiatives in MSK disorders. One example: a quantitative scoring system he and colleagues are proposing for evaluating new technologies aims to reduce variability and subjectivity in decision making.
In the ALLEVIATE-HF clinical trial, continuous monitoring provided by Medtronic’s insertable cardiac monitor revealed a substantial burden of previously unsuspected arrhythmias in patients with both HFrEF and HFpEF—many of whom would not ordinarily qualify for an implantable cardiac device.